Atlantic Healthcare (AgeTech UK) Biomed

Gastrointestinal diseases, owns the worldwide rights to renzapride, a molecule, work also on orphan diseases. Currently developing differentiated, first-in-class treatments that leverage alicaforsen, an antisense therapeutic agent with a novel target for validated mechanism of action and the potential to treat multiple inflammatory GI diseases.

Founded Date: N/A
Headquarters: United Kingdom
Technology: AgeTech Companies
Employee Number: N/A
Industry: UK AgeTech 2020
Number Of Exists: N/A
Funding Status: N/A
Investor Type: N/A
Investment Stage: N/A